Skip to main content
♕ The Globe and Mail Trade Off
Canada's free stock market contest is live! Test your investing skills for a chance to win $5,000.Enter Now!Enter Now!
➜

CVS Corp(CVS-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low76.93
Day High78.86
Open:78.77
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: CVS Corp

Select a category then submit the form to load news
Tipranks
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), CVS Health (CVS) and Immunome (IMNM)
Motley Fool
2 Top Healthcare Stocks to Buy in February
Tipranks
CVS Health put volume heavy and directionally bearish
Tipranks
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Janux Therapeutics Inc (JANX) and CVS Health (CVS)
Motley Fool
Brightstar Lottery Stock Down 26% as Investor Sells $10 Million in Shares Amid $629 Million Quarter
Motley Fool
This Fund's New $14 Million Stake in Cal-Maine Foods Signals Conviction Even as Income Sank 50% Last Quarter
Motley Fool
Braze Stock Down 59%, so Why Did One Fund Just Invest Another $16 Million in Shares?
Motley Fool
Higher Bond Income or Greater Capital Stability: VCSH vs. BSV
StockStory
The Top 5 Analyst Questions From CVS Health’s Q4 Earnings Call
CVS
Motley Fool
Kiltearn Partners Exits Sealed Air Position
Motley Fool
Kiltearn Bought 265,000 LKQ Shares for an $8 Million Bet on the Auto Parts Industry
Tipranks
Oppenheimer Keeps Their Hold Rating on CVS Health (CVS)
Tipranks
Evercore ISI Sticks to Their Buy Rating for CVS Health (CVS)
Tipranks
RBC Capital Reaffirms Their Buy Rating on CVS Health (CVS)
Tipranks
CVS Health Earnings Call: Cash, Growth And Cost Risks
Motley Fool
Biotech Beat Nvidia in 2025. Can It Do It Again?
Motley Fool
CVS Health (CVS) Q4 2025 Earnings Call Transcript
StockStory
CVS Q4 Deep Dive: Pharmacy Turnaround and Regulatory Shifts Shape Outlook
CVS
StockStory
CVS Health (NYSE:CVS) Surprises With Q4 CY2025 Sales
CVS
ValuEngine, Inc
02/09/2026 ValuEngine Weekly Market Summary & Commentary
StockStory
CVS Health (CVS) Q4 Earnings: What To Expect
CVS
Motley Fool
SPLB And TLT Both Offer Strong Dividend Yield
Motley Fool
Should You Buy CVS Health Stock Before Feb. 10?
Motley Fool
Is CVS Health Stock a Bad-News Buy?
Tipranks
Analysts Conflicted on These Healthcare Names: CVS Health (CVS), Madrigal Pharmaceuticals (MDGL) and Xenon (XENE)
Zacks Investment Research
Should Investors Buy, Sell or Hold Lilly Stock Ahead of Q4 Earnings?
Should Investors Buy, Sell or Hold Lilly Stock Ahead of Q4 Earnings?
Zacks Investment Research
Healthcare ETFs in Focus as UnitedHealth Rises 4% Post Mixed Q4 Results
Healthcare ETFs in Focus as UnitedHealth Rises 4% Post Mixed Q4 Results
Motley Fool
Should You Buy UnitedHealth Group Stock After Its Steep Sell-Off?
Tipranks
Analysts’ Top Healthcare Picks: CVS Health (CVS), Revolution Medicines (RVMD)
Tipranks
Bernstein Keeps Their Hold Rating on CVS Health (CVS)
StockStory
3 S&P 500 Stocks We’re Skeptical Of
WDAY
Motley Fool
Corporate Bonds vs. Treasuries: What Your Defensive Allocation Is Built On

Profile

CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.